Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 3/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4061116 | 0.85 | CA12 (0.32) | CA1CA2CA9TDP1CA12 | |
| Benzene SCHEMBL28943358 | 0.82 | TDP1 (0.44) | CA1CA2CA9TDP1CA12 | |
| SCHEMBL49343 | 0.82 | TDP1 (0.44) | CA1CA2CA9TDP1CA12 | |
| Benzene SCHEMBL4445625 | 0.82 | TDP1 (0.44) | CA1CA2CA9TDP1CA12 | |
| SCHEMBL6551816 | 0.81 | — | — | |
| SCHEMBL9618209 | 0.81 | ALDH1A1 (0.43) | CA1CA2CA9TDP1CA12 | |
| SCHEMBL1516323 | 0.81 | CA2 (0.43) | CA1CA2CA9TDP1CA12 | |
| SCHEMBL22882956 | 0.81 | ACHE (0.35) | ALDH1A1TSHRACHE | |
| SCHEMBL2933394 | 0.81 | TSHR (0.43) | CA1CA2CA9TDP1ALDH1A1 | |
| SCHEMBL8745400 | 0.81 | TSHR (0.43) | ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024108774-A1 | METAL-CATALYZED DOUBLE HYDROBORATION OF NITROGEN HETEROCYCLICS | GUANGDONG TECHNION-ISRAEL INSTITUTE OF TECHNOLOGY (CN) | 2024-05-30 | — | — | WO | claimed |
| EP-2850087-B1 | BETA-BORATION OF ALKENE AND ALKYNE INTERMEDIATES | LEK PHARMACEUTICALS (SI) | 2017-08-02 | — | — | EP | claimed |
| CN-104603142-A | Beta-boronation of alkene and alkyne intermediates | LEK PHARMACEUTICALS | 2015-05-06 | — | — | CN | claimed |
| CN-102414162-B | Process for the preparation of vinyl esters from acetylene and carboxylic acids using homogeneous catalysts | CELANESE INTERNATIONAL CORP. (US) | 2014-10-29 | — | — | CN | claimed |
| EP-2427419-B1 | VINYL ESTER PRODUCTION FROM ACETYLENE AND CARBOXYLIC UTILIZING HOMOGENEOUS CATALYST | CELANESE INT CORP (US) | 2014-06-18 | — | — | EP | claimed |
| EP-2647639-A1 | ß-boration of alkene and alkyne intermediates | LEK Pharmaceuticals d.d. (SI) | 2013-10-09 | — | — | EP | claimed |
| EP-2647640-A1 | ß-boration of alkene and alkyne intermediates | LEK Pharmaceuticals d.d. (SI) | 2013-10-09 | — | — | EP | claimed |
| US-8536367-B2 | Vinyl ester production from acetylene and carboxylic acid utilizing homogeneous catalyst | CELANESE INTERNATIONAL CORP. (US) | 2013-09-17 | — | — | US | claimed |
| US-8173830-B2 | For example, reacting acetyene and benzoic acid or neodecanoic acid to make vinyl benzoate or vinyl neodecanoate respectively on industrial scale using a iridium, palladium, platinum, or rhodium complex catalyst with use of certain ligands and additives | CELANESE INTERNATIONAL CORPORATION (US) | 2012-05-08 | — | — | US | claimed |
| CN-102421743-A | Vinyl ester production from acetylene and carboxylic acid utilizing heterogeneous catalyst | CELANESE INT CORP | 2012-04-18 | — | — | CN | claimed |
| CN-102414162-A | Process for the preparation of vinyl esters from acetylene and carboxylic acids using homogeneous catalysts | CELANESE INT CORP | 2012-04-11 | — | — | CN | claimed |
| EP-2427419-A2 | VINYL ESTER PRODUCTION FROM ACETYLENE AND CARBOXYLIC UTILIZING HOMOGENEOUS CATALYST | Celanese International Corporation (US) | 2012-03-14 | — | — | EP | claimed |
| US-7982065-B2 | Vinyl ester production from acetylene and carboxylic acid utilizing heterogeneous catalyst | CELANESE INTERNATIONAL CORPORATION (US) | 2011-07-19 | — | — | US | claimed |
| US-20100286441-A1 | Vinyl Ester production from Acetylene and Carboxylic Acid utilizing heterogeneous catalyst | CELANESE INTERNATIONAL CORPORATION | 2010-11-11 | — | — | US | claimed |
| US-20100286440-A1 | Vinyl Ester production from Acetylene and Carboxylic Acid utilizing homogeneous catalyst | CELANESE INTERNATIONAL CORPORATION (US) | 2010-11-11 | — | — | US | claimed |
| WO-2010129030-A2 | VINYL ESTER PRODUCTION FROM ACETYLENE AND CARBOXYLIC UTILIZING HOMOGENEOUS CATALYST | CELANESE INTERNATIONAL CORPORATION (US) | 2010-11-11 | — | — | WO | claimed |
| EP-0128597-B1 | ETHYLENE OLIGOMERIZATION PROCESS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-10-07 | — | — | EP | claimed |
| EP-0128596-B1 | ETHYLENE OLIGOMERIZATION PROCESS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-05-20 | — | — | EP | claimed |
| WO-2024108774-A1 | METAL-CATALYZED DOUBLE HYDROBORATION OF NITROGEN HETEROCYCLICS | GUANGDONG TECHNION-ISRAEL INSTITUTE OF TECHNOLOGY (CN) | 2024-05-30 | — | — | WO | disclosed |
| US-6084133-A | REACTING A PHOSPHINE HALIDE WITH A METAL, THEN PROTONATION RESULTING DIORGANO-SUBSTITUTED METAL PHOSPHIDE; SIMPLIFICATION, NONTOXIC, EFFICIENCY | KANKYO KAGAKU CENTER CO., LTD. (JP) | 2000-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286441-A1 | Vinyl Ester production from Acetylene and Carboxylic Acid utilizing heterogeneous catalyst | ACACA, ACACB, PCCA | CA1 32/4885CA2 168/4885CA9 163/4885 |
| US-20100286440-A1 | Vinyl Ester production from Acetylene and Carboxylic Acid utilizing homogeneous catalyst | ACACA, ACACB, ELL | CA1 85/4885CA2 84/4885CA9 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.